Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
31 minute read
  • Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights
Today, 9:42 PM
  On Wednesday, 479 stocks made new 52-week lows.

AAP

Read More
1 minute read
  • Dividends
  • General
  • News
  • Small Cap

SpartanNash Boosts Dividend By 2.4%

By Shivani Kumaresan
Today, 9:42 PM
SpartanNash Co (NASDAQ:SPTN) said its Board of Directors approved a 2.4% increase in quarterly cash dividend The revised dividend now amounts to $0.215 per…

SPTN

Read More
4 minute read
  • Cannabis
  • Entrepreneurship
  • General
  • Markets
  • Movers & Shakers
  • News
  • Penny Stocks
  • Small Cap

Key Marijuana Executive Changes You Should Know About. New Appointments & More

By Jelena Martinovic
Today, 9:42 PM
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari

AGFAF

Read More
17 minute read
  • Earnings

Earnings Scheduled For February 23, 2023

By Benzinga Insights
Today, 9:42 PM
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

AAOI

Read More
15 minute read
  • Analyst Ratings
  • Downgrades
  • Initiation
  • Intraday Update
  • Upgrades

Benzinga’s Top Ratings Upgrades, Downgrades For December 1, 2022

By Benzinga Insights
Today, 9:42 PM
Upgrades Northcoast Research upgraded the previous rating for SpartanNash Co (NASDAQ:SPTN) from Neutral to Buy. SpartanNash earned $0.55…

ACRS

Read More
2 minute read
  • News

SpartanNash, Shipt Announce Expansion Of Same-Day Delivery Partnership

By Benzinga Newsdesk
Today, 9:42 PM
Food solutions company SpartanNash (the "Company") (NASDAQ:SPTN) today announced its growing partnership with same-day delivery service Shipt. Shipt users will now be able to shop nearly 90

SPTN

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Deutsche Bank Maintains Hold on SpartanNash, Raises Price Target to $36

By Benzinga Newsdesk
Today, 9:42 PM
Deutsche Bank analyst Krisztina Katai maintains SpartanNash (NASDAQ:SPTN) with a Hold and raises the price target from $26 to $36.

SPTN

Read More
1 minute read
  • Dividends
  • Earnings
  • News

If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,100 Today

By Benzinga Insights
Today, 9:42 PM
SpartanNash (NASDAQ:SPTN) has outperformed the market over the past 20 years by 4.8% on an annualized basis producing an average annual return of 12.61%. Currently, SpartanNash has a market capitalization of $1.18 billion.

SPTN

Read More
1 minute read
  • Earnings
  • Guidance
  • News
  • Small Cap

SpartanNash Q2 Earnings Exceed Expectations

By Shivani Kumaresan
Today, 9:42 PM
SpartanNash Co (NASDAQ:SPTN) reported second-quarter FY22 sales growth of 7.9% year-on-year to $2.27 billion, beating the consensus of $2.13 billion. The…

SPTN

Read More
3 minute read
  • Earnings

Earnings Scheduled For August 18, 2022

By Benzinga Insights
Today, 9:42 PM
  Companies Reporting Before The Bell • Calliditas Therapeutics (NASDAQ:CALT) is expected to report quarterly loss at $1.00 per share on revenue of $7.50 million.

ADXN

Posts navigation

1 2 … 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service